Dec 23 () - A patient who was being treated with Pfizer's hemophilia drug, Hympavzi, as part of a ​long-term study died after experiencing serious side effects, the ‌company said. The individual died on December 14 after suffering a stroke followed by ‌a brain hemorrhage, according to the European Haemophilia Consortium, a patient support group.

Rome court said Netflix's Italy price hikes broke consumer protection law.

The gig economy has changed the manner in which individuals work, offering phenomenal adaptability and open doors for cheaplancers. In this article, we'll